Vimarsana
Biggest News Aggregation in the World

Scidev Netthat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scidev Netthat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scidev Netthat Today - Breaking & Trending Today

Breastfeeding during the rainy season protects infants against environmental enteric dysfunction - Vimarsana News

Breastfeeding during the rainy season protects infants against environmental enteric dysfunction

Breastfeeding infants continuously for six months during the rainy season, without including any other foods, may help prevent a disease linked to micronutrient deficiencies, a study suggests.

Failure to invest in global health left the world ill-prepared for COVID-19, experts say - Vimarsana News

Failure to invest in global health left the world ill-prepared for COVID-19, experts say

A key meeting of the WHO's executive board has spawned an upswell of calls to overhaul the UN agency's funding, with leaders saying failure to invest in global health left the world ill-prepared for the COVID-19 "tsunami of suffering".

Citizen-generated data could help fight antimicrobial resistance - Vimarsana News

Citizen-generated data could help fight antimicrobial resistance

Citizen-generated data could help combat the misuse of medicines and prevent antimicrobial resistance (AMR), says a report by the Global Partnership for Sustainable Development Data (GPSDD).

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis - Vimarsana News

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis

New drug cocktail offers hope to patients with highly drug-resistant tuberculosis A new three-drug, all-oral, six-month treatment is providing hope to patients in Tajikistan with highly drug-resistant forms of tuberculosis, which until now had limited treatment options and poor prognosis. Tajikistan is the first country in Central Asia and second in the world after Ukraine to provide access to the novel 'BPaL' regimen to patients suffering from the extensively drug-resistant (XDR-TB) form of tuberculosis under operational research conditions from December 2020. The regimen consists of three d...